Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Skorokhod

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 25, 2015
Universal BRAF State Detection by the Pyrosequencing®-Based U-BRAF(V⁶⁰⁰) AssayAlexander Skorokhod
The Journal of Investigative Dermatology|June 14, 2014
Opening a niche for therapy: local lymphodepletion helps the immune system to fight melanomaKarsten Mahnke, Alexander Skorokhod, Stefan Grabbe, et al.
Plos One|April 5, 2013
Automated universal BRAF state detection within the activation segment in skin metastases by pyrosequencing-based assay U-BRAF(V600)Alexander Skorokhod, Peter Helmbold, Benedikt Brors, et al.
BMC Cancer|June 23, 2012
Real-imaging cDNA-AFLP transcript profiling of pancreatic cancer patients: Egr-1 as a potential key regulator of muscle cachexiaAlexander Skorokhod, Jeannine Bachmann, Nathalia A Giese, et al.
Gene|October 2, 2002
Conservation of the positions of metazoan introns from sponges to humansWerner E G Müller, Markus Böhm, Vladislav A Grebenjuk, et al.
The Journal of Investigative Dermatology|November 25, 2011
RASSF10 promoter hypermethylation is frequent in malignant melanoma of the skin but uncommon in nevus cell neviPeter Helmbold, Antje M Richter, Sara Walesch, et al.
Plos One|November 28, 2017
Variables that influence BRAF mutation probability: A next-generation sequencing, non-interventional investigation of BRAFV600 mutation status in melanomaMaria Rita Gaiser, Alexander Skorokhod, Diana Gransheier, et al.
Immunogenetics|April 27, 2002
Histocompatibility reaction in tissue and cells of the marine sponge Suberites domuncula in vitro and in vivo: central role of the allograft inflammatory factor 1Werner E G Müller, Anatoli Krasko, Alexander Skorokhod, et al.
International Journal of Cancer|August 3, 2018
TERT promoter mutation subtypes and survival in stage I and II melanoma patientsJuan J Andrés-Lencina, Sivaramakrishna Rachakonda, Zaida García-Casado, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cellsPaul Gutwein, Alexander Stoeck, Svenja Riedle, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|June 25, 2015
Universal BRAF State Detection by the Pyrosequencing®-Based U-BRAF(V⁶⁰⁰) AssayAlexander Skorokhod
The Journal of Investigative Dermatology|June 14, 2014
Opening a niche for therapy: local lymphodepletion helps the immune system to fight melanomaKarsten Mahnke, Alexander Skorokhod, Stefan Grabbe, et al.
Plos One|April 5, 2013
Automated universal BRAF state detection within the activation segment in skin metastases by pyrosequencing-based assay U-BRAF(V600)Alexander Skorokhod, Peter Helmbold, Benedikt Brors, et al.
BMC Cancer|June 23, 2012
Real-imaging cDNA-AFLP transcript profiling of pancreatic cancer patients: Egr-1 as a potential key regulator of muscle cachexiaAlexander Skorokhod, Jeannine Bachmann, Nathalia A Giese, et al.
Gene|October 2, 2002
Conservation of the positions of metazoan introns from sponges to humansWerner E G Müller, Markus Böhm, Vladislav A Grebenjuk, et al.
The Journal of Investigative Dermatology|November 25, 2011
RASSF10 promoter hypermethylation is frequent in malignant melanoma of the skin but uncommon in nevus cell neviPeter Helmbold, Antje M Richter, Sara Walesch, et al.
Plos One|November 28, 2017
Variables that influence BRAF mutation probability: A next-generation sequencing, non-interventional investigation of BRAFV600 mutation status in melanomaMaria Rita Gaiser, Alexander Skorokhod, Diana Gransheier, et al.
Immunogenetics|April 27, 2002
Histocompatibility reaction in tissue and cells of the marine sponge Suberites domuncula in vitro and in vivo: central role of the allograft inflammatory factor 1Werner E G Müller, Anatoli Krasko, Alexander Skorokhod, et al.
International Journal of Cancer|August 3, 2018
TERT promoter mutation subtypes and survival in stage I and II melanoma patientsJuan J Andrés-Lencina, Sivaramakrishna Rachakonda, Zaida García-Casado, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cellsPaul Gutwein, Alexander Stoeck, Svenja Riedle, et al.
Pageof 1